tradingkey.logo

Perrigo Company PLC

PRGO
查看详细走势图
15.065USD
+0.125+0.84%
收盘 01/13, 16:00美东报价延迟15分钟
2.07B总市值
亏损市盈率 TTM

Perrigo Company PLC

15.065
+0.125+0.84%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+0.84%

5天

+2.14%

1月

+14.65%

6月

-45.28%

今年开始到现在

+8.23%

1年

-38.11%

查看详细走势图

TradingKey Perrigo Company PLC股票评分

单位: USD 更新时间: 2026-01-13

操作建议

Perrigo Company PLC当前公司基本面数据相对健康,增长潜力很大。当前估值合理,在药品行业排名46/159位。机构持股占比非常高,近一月多位分析师给出公司评级为持有。最高目标价18.67。中期看,股价处于下降通道。近一个月,市场表现很强,技术面和基本面综合得分较高,很强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。

Perrigo Company PLC评分

相关信息

行业排名
46 / 159
全市场排名
143 / 4563
所属行业
药品

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
看好

Perrigo Company PLC亮点

亮点风险
Perrigo Company plc is a provider of over the counter (OTC) health and wellness solutions that are designed to enhance individual well-being. Its segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises of its consumer self-care business in the United States and Canada. It primarily provides its customers self-care products that are sold and marketed under the customer's own brands and/or exclusive brands. The CSCI segment comprises of its consumer self-care business outside of the United States and Canada, primarily in Europe and Australia. These products are developed, manufactured, marketed, and distributed by the Company. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, and Nutrition. Its primary branded products are sold under brand names Compeed, Dr. Fresh, Firefly, Good Sense, Mederma, Nasonex, Solpadeine, Coldrex, and Physiomer, among others.
利润高增长
公司净利润处于行业前列,最新年度总收入4.37B美元
估值合理
公司最新PE估值-40.08,处于3年历史合理位
机构减仓
最新机构持股155.20M股,环比减少9.33%
Keeley-Teton 顾问公司持仓
明星投资者Keeley-Teton 顾问公司持仓,最新持仓市值375.68K
活跃度增加
近期活跃度增加,过去20天平均换手率0.25

分析师目标

根据 4 位分析师
持有
评级
18.667
目标均价
+23.78%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Perrigo Company PLC新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Perrigo Company PLC简介

Perrigo Company plc is a provider of over the counter (OTC) health and wellness solutions that are designed to enhance individual well-being. Its segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises of its consumer self-care business in the United States and Canada. It primarily provides its customers self-care products that are sold and marketed under the customer's own brands and/or exclusive brands. The CSCI segment comprises of its consumer self-care business outside of the United States and Canada, primarily in Europe and Australia. These products are developed, manufactured, marketed, and distributed by the Company. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, and Nutrition. Its primary branded products are sold under brand names Compeed, Dr. Fresh, Firefly, Good Sense, Mederma, Nasonex, Solpadeine, Coldrex, and Physiomer, among others.
公司代码PRGO
公司Perrigo Company PLC
CEOLockwood-Taylor (Patrick)
网址https://www.perrigo.com/

常见问题

Perrigo Company PLC(PRGO)的当前股价是多少?

Perrigo Company PLC(PRGO)的当前股价是 15.065。

Perrigo Company PLC的股票代码是什么?

Perrigo Company PLC的股票代码是PRGO。

Perrigo Company PLC股票的52周最高点是多少?

Perrigo Company PLC股票的52周最高点是30.930。

Perrigo Company PLC股票的52周最低点是多少?

Perrigo Company PLC股票的52周最低点是12.170。

Perrigo Company PLC的市值是多少?

Perrigo Company PLC的市值是2.07B。

Perrigo Company PLC的净利润是多少?

Perrigo Company PLC的净利润为-171.80M。

现在Perrigo Company PLC(PRGO)的股票是买入、持有还是卖出?

根据分析师评级,Perrigo Company PLC(PRGO)的总体评级为持有,目标价格为18.667。

Perrigo Company PLC(PRGO)股票的每股收益(EPS TTM)是多少

Perrigo Company PLC(PRGO)股票的每股收益(EPS TTM)是-0.376。
KeyAI